Clinical course of pneumonia in lung cancer Source: Eur Respir J 2005; 26: Suppl. 49, 326s Year: 2005
Screening for incidence of lung cancer (LC) among the patients with pulmonary pathology (with special reference to histological subtype and TNM-staging system) in Ukraine Source: Eur Respir J 2005; 26: Suppl. 49, 537s Year: 2005
Frequency and clinicopathologic features of organizing pneumonia adjacent to lung cancer Source: Eur Respir J 2001; 18: Suppl. 33, 526s Year: 2001
Treatment and prognosis of lung cancer associated with interstitial pneumonia Source: Annual Congress 2010 - Thoracic malignancies: interesting case studies and series Year: 2010
Impact of neutrophil function on outcomes of community-acquired pneumonia (CAP) in patients with cancer Source: Annual Congress 2007 - Community-acquired pneumonia: from aetiology to complication Year: 2007
Clinical and functional characteristics of patients with unclassifiable interstitial lung diseases (uILD) from eurIPFreg. Source: Virtual Congress 2020 – Predictive markers of progression in connective tissue disease-associated interstitial lung disease and hypersensitivity pneumonitis Year: 2020
Epidemiology, clinical, imaging and histology aspects of lung cancer in IPF Source: Research Seminar 2015 Year: 2015
Evaluate of radiological, bronchoscopical and histopathological features of patients with primary lung cancer Source: Annual Congress 2008 - Diagnostic aspects in thoracic oncology Year: 2008
Clinical factors associated with delayed diagnosis in hospitalized community-acquired pneumonia (CAP). Impact on the outcome Source: Annual Congress 2010 - Risk factors and outcomes in community-acquired pneumonia Year: 2010
Incidence of interstitial lung disease (ILD) and risk factors for developing ILD: A final analysis of a large-scale erlotinib Japanese surveillance study in non-small-cell lung cancer (NSCLC) Source: Annual Congress 2013 –Connective tissue disease and interstitial lung disease Year: 2013
Scintigraphic parameters in differential diagnostics of community acquired pneumonia and lung cancer Source: Annual Congress 2009 - Management of thoracic malignancies Year: 2009
Clinical features and prognosis of multiple primary malignancies in patients with lung cancer Source: Annual Congress 2013 –Other thoracic tumours, particular circumstances and rare cases Year: 2013
Prevalence and clinical characteristics of lung cancer with COPD Source: Eur Respir J 2005; 26: Suppl. 49, 321s Year: 2005
Clinical and radiographical features of new-diagnosed lung cancer Source: Eur Respir J 2003; 22: Suppl. 45, 252s Year: 2003
Clinical and molecular analysis of lung cancer associated with fibrosing and diffuse interstitial lung disease. Source: Virtual Congress 2021 – New clinical and biological developments in lung cancer Year: 2021
Patient outcome and factors influencing lack of histology in patients with clinical diagnosis of lung cancer Source: Annual Congress 2013 –Quality management in thoracic oncology Year: 2013
Clinical evaluation of patients with lung carcinoma Source: Eur Respir J 2002; 20: Suppl. 38, 437s Year: 2002
Clinical characteristic of lung cancer patients with interstitial pneumonia treated with chemotherapy or radiotherapy Source: Annual Congress 2008 - Therapy of thoracic tumours Year: 2008
Clinical, radiological and bacteriological features in geriatric tuberculosis (TB) patients (pts) - initial treatment and outcome Source: Eur Respir J 2002; 20: Suppl. 38, 363s Year: 2002